The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...

Patients with moderate to severe allergic rhinitis (AR) often experience years of uncontrolled symptoms, worsened quality of ...

Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...

Research reveals that socioeconomic status significantly impacts survival rates in young adults with metastatic colorectal ...

A multistakeholder study explores how law enforcement presence in EDs affects survivors of violence and outlines ...

CCCA patients experience longer diagnostic delays, with a mean TTD of 5.67 years, compared to other scarring alopecias. Black patients face longer diagnostic delays, but alopecia subtype is the only ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Federal homelessness prevention programs, like VA SSVF, improve health outcomes and reduce healthcare costs for veterans.

An interactive smart speaker intervention reduced mental distress and improved diabetes-related outcomes in older adults with type 2 diabetes. Participants using the virtual assistant showed ...

In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...

IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...

Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...